Insight Molecular Diagnostics To Present Two Oral Abstracts At World Transplant Congress
Benzinga Newsdesk 1 year ago
BiotechNewsGeneral
iMDx first dd-PCR assay to combine relative and absolute measurements of dd-cfDNA into single combined scoreData show significantly improved positive predictive value (PPV) for graft rejection, which potentially broadens
- iMDx first dd-PCR assay to combine relative and absolute measurements of dd-cfDNA into single combined score
- Data show significantly improved positive predictive value (PPV) for graft rejection, which potentially broadens clinical utility for dd-cfDNA with fewer false positives, further reducing unnecessary invasive biopsies for patients
- iMDx expects to evaluate combined score in ongoing FDA study (NCT07060716)
- iMDx will be exhibiting at Booth #324 at the World Transplant Congress
- National Principal Investigator and Key Opinion Leader call Friday, August 15th at 4 p.m. ET to discuss GraftAssureTM - branded family of assays